Recipharm has signed a licensing agreement with Altus Formulation Inc., a Canadian drug development company, to allow its customers to access new drug delivery technologies and products.   Recipharm will co-develop new value added medicines for its customers utilizing Altus’ patented Intellitab and Flexitab drug delivery technologies.   Intellitab is a novel misuse and abuse deterrent technology that mitigates the dangers of over-exposure to opioids that can occur due to inadvert...